A Pilot Study of Interstitial Photodynamic Therapy for Recurrent Squamous Cell Carcinoma of the Oropharynx and Oral Cavity
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2015
At a glance
- Drugs Temoporfin (Primary)
- Indications Head and neck cancer; Oropharyngeal cancer
- Focus Adverse reactions
- 02 Apr 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 21 Aug 2014 Planned End Date changed from 1 Sep 2014 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
- 01 Dec 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.